RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Natus Medical Stock

Natus Medical Net Income 2024

Natus Medical Net Income

63.59 M USD

Ticker

NTUS

ISIN

US6390501038

WKN

578916

In 2024, Natus Medical's profit amounted to 63.59 M USD, a 14.83% increase from the 55.38 M USD profit recorded in the previous year.

The Natus Medical Net Income history

YEARNET INCOME (undefined USD)
2025e74.48
2024e63.59
2023e55.38
2022e50.8
202113.18
2020-16.6
2019-15.7
2018-22.9
2017-20.3
201642.6
201537.9
201432.5
201323.1
20123.8
2011-11.2
201011.9
200911.4
200817.3
20079.8
2006-0.9
20056.2
2004-2.4
2003-2.7
2002-7.5

Natus Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Natus Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Natus Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Natus Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Natus Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Natus Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Natus Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Natus Medical’s growth potential.

Natus Medical Revenue, EBIT and net profit per share

DateNatus Medical RevenueNatus Medical EBITNatus Medical Net Income
2025e567.94 M undefined449.38 M undefined74.48 M undefined
2024e541.97 M undefined179.75 M undefined63.59 M undefined
2023e527.54 M undefined73.34 M undefined55.38 M undefined
2022e504.9 M undefined66.91 M undefined50.8 M undefined
2021473.44 M undefined29.38 M undefined13.18 M undefined
2020415.7 M undefined-10 M undefined-16.6 M undefined
2019495.2 M undefined29 M undefined-15.7 M undefined
2018530.9 M undefined12.6 M undefined-22.9 M undefined
2017501 M undefined9.6 M undefined-20.3 M undefined
2016381.9 M undefined56.8 M undefined42.6 M undefined
2015375.9 M undefined55.6 M undefined37.9 M undefined
2014355.8 M undefined50.1 M undefined32.5 M undefined
2013344.1 M undefined39.5 M undefined23.1 M undefined
2012292.3 M undefined14.5 M undefined3.8 M undefined
2011232.9 M undefined13.2 M undefined-11.2 M undefined
2010218.4 M undefined21.3 M undefined11.9 M undefined
2009166.4 M undefined15.5 M undefined11.4 M undefined
2008161.8 M undefined25.2 M undefined17.3 M undefined
2007118.4 M undefined16.2 M undefined9.8 M undefined
200689.9 M undefined12.7 M undefined-900,000 undefined
200543 M undefined5.4 M undefined6.2 M undefined
200436.5 M undefined-200,000 undefined-2.4 M undefined
200331 M undefined-3.2 M undefined-2.7 M undefined
200227 M undefined-8.6 M undefined-7.5 M undefined

Natus Medical stock margins

The Natus Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Natus Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Natus Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Natus Medical's sales revenue. A higher gross margin percentage indicates that the Natus Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Natus Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Natus Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Natus Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Natus Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Natus Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Natus Medical Margin History

Natus Medical Gross marginNatus Medical Profit marginNatus Medical EBIT marginNatus Medical Profit margin
2025e57.7 %79.12 %13.11 %
2024e57.7 %33.17 %11.73 %
2023e57.7 %13.9 %10.5 %
2022e57.7 %13.25 %10.06 %
202157.7 %6.21 %2.78 %
202053.62 %-2.41 %-3.99 %
201958.91 %5.86 %-3.17 %
201857.26 %2.37 %-4.31 %
201756.13 %1.92 %-4.05 %
201661.51 %14.87 %11.15 %
201560.52 %14.79 %10.08 %
201460.26 %14.08 %9.13 %
201358.82 %11.48 %6.71 %
201255.87 %4.96 %1.3 %
201156.38 %5.67 %-4.81 %
201059.43 %9.75 %5.45 %
200960.34 %9.31 %6.85 %
200862.11 %15.57 %10.69 %
200763.6 %13.68 %8.28 %
200662.63 %14.13 %-1 %
200562.79 %12.56 %14.42 %
200458.9 %-0.55 %-6.58 %
200358.71 %-10.32 %-8.71 %
200255.19 %-31.85 %-27.78 %

Natus Medical Aktienanalyse

What does Natus Medical do?

Natus Medical Inc is a US-American medical technology company that operates in two main areas: neurology and neonatal care. The company was founded in 1989 under the name "Neometrics" and has since conducted numerous acquisitions, thus expanding into new areas. The business model of Natus Medical Inc is focused on providing state-of-the-art medical technologies that improve the diagnosis and treatment of patients. The company works closely with medical professionals, hospitals, and clinics to ensure the best possible patient care. The neurology division of Natus Medical Inc focuses on providing diagnostic tools for the diagnosis and monitoring of neurological disorders such as epilepsy, stroke, multiple sclerosis, and the like. Products include electroencephalography (EEG) and electromyography (EMG) devices, neurofeedback systems, and software for reporting. The neonatal care division of Natus Medical Inc offers a wide range of products for the care of premature and newborn infants. These include incubators, ventilators, monitoring devices, and phototherapy systems. Natus Medical Inc products are used in clinics and neonatology departments around the world and aim to improve the health and well-being of newborns. With the acquisition of Otometrics and Bio-logic Systems, Natus Medical Inc has expanded its product range to include audiology products. The audiology division offers a wide range of diagnostic tools for audiologists and ENT physicians, including comprehensive audiometric testing devices for children and adults, balance testing devices, and OAE screening systems. Natus Medical Inc places great emphasis on research and development and continuously invests in new technologies to provide even more effective diagnostic and treatment options for patients. The company is also dedicated to the education and training of healthcare personnel by offering trainings and continuing education for medical staff, as well as comprehensive technical support for the users of its products. Looking to the future, Natus Medical Inc plans further expansion, particularly on an international level. The company already has a strong presence in North America and now aims to expand in Europe and Asia. The company focuses on adapting its products and services to the different needs and requirements of each market. Overall, Natus Medical Inc is an innovative and future-oriented company that provides state-of-the-art medical technologies for the diagnosis and treatment of patients. With continuous investments in research and development, as well as its strong presence in the international market, the company is well positioned to continue growing and maintain its leading position in the medical technology industry. Natus Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Natus Medical's Profit Margins

The profit margins of Natus Medical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Natus Medical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Natus Medical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Natus Medical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Natus Medical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Natus Medical stock

How much profit has Natus Medical made this year?

Natus Medical has made 63.59 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 14.83% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Natus Medical publish its earnings?

Natus Medical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Natus Medical?

The profits of Natus Medical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Natus Medical?

You can learn more about the earnings of Natus Medical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Natus Medical pay?

Over the past 12 months, Natus Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Natus Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Natus Medical?

The current dividend yield of Natus Medical is .

When does Natus Medical pay dividends?

Natus Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Natus Medical?

Natus Medical paid dividends every year for the past 0 years.

What is the dividend of Natus Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Natus Medical located?

Natus Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Natus Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Natus Medical from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Natus Medical pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Natus Medical in the year 2023?

In the year 2023, Natus Medical distributed 0 USD as dividends.

In which currency does Natus Medical pay out the dividend?

The dividends of Natus Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Natus Medical

Our stock analysis for Natus Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Natus Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.